Metabolomics profiling of seminal plasma in obesity‐induced asthenozoospermia
Andrology · 2023-10 · 11 (7) · 1303-1319
DOI: 10.1111/andr.13412 ↗At a glance
Journal article in Andrology, published online on 2023-03-20. Written by Yan-Fen Zhou and 7 co-authors. Institution: College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China. Major MEDLINE topics: Semen, Asthenozoospermia. Cited 26 times so far (Crossref); 32 references. Funded by: Jiangsu Provincial Key Research and Development Program.
Abstract (original language)
Background
Asthenozoospermia is one of the essential causes of male infertility, and its incidence is significantly higher in obese men. Due to its complex etiology and unknown pathomechanism, the diagnosis and treatment of obesity‐induced asthenozoospermia is a prevalent problem in reproductive medicine.
Objective
This study aims to explore major differential metabolites and metabolic pathways in seminal plasma and pathological mechanisms for obesity‐induced asthenozoospermia. Materials and Methods We performed non‐target metabolomic studies on the seminal plasma of healthy men with normal semen parameters (HN group, n = 20), obese men with normal semen parameters (ON group, n = 20), and men with obesity‐induced asthenozoospermia (OA group, n = 20) based on gas chromatography‐mass spectrometry. Metabolic profilings and related pathway analyses were conducted to discriminate differential metabolites and metabolic pathways.
Results
A total of 20 differential metabolites including fructose, succinic acid, aconitic acid, methylmaleic acid, glucopyranose, serine, valine, leucine, phenylalanine, glycine, glutamic acid, alanine, proline and threonine were identified in HN group and ON group; 24 differential metabolites including glucose, fructose, pyruvic acid, citric acid, succinic acid, aconitic acid, glucopyranose, glutamic acid, valine, leucine, glycine, phenylalanine, lysine, citrulline, proline and alanine were produced in OA group and ON group; and 28 differential metabolites including glucose, fructose, citric acid, succinic acid, glucopyranose, valine, glycine, serine, leucine, phenylalanine, alanine, threonine, proline, glutamic acid, citrulline, lysine and tyrosine were produced in OA group and HN group. In addition, abnormal energy metabolism including carbohydrate metabolism (TCA cycle, glycolysis/gluconeogenesis, and pyruvate metabolism) and amino acid metabolism (phenylalanine, tyrosine, and tryptophan biosynthesis, D‐glutamine and D‐glutamate metabolism; phenylalanine metabolism, etc.) were found in ON group and OA group.
Conclusion
Obesity could affect the metabolite composition in seminal plasma and abnormal energy metabolism in seminal plasma mainly including carbohydrate metabolism and amino acid metabolism were closely related to obesity‐induced asthenozoospermia.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- College of Biotechnology and Pharmaceutical Engineering, Nanjing Tech University, Nanjing, China.
- College of Pharmaceutical Sciences, Nanjing Tech University, Nanjing, China.
- Department of Urology, Affiliated Drum Tower Hospital, Medical School of Nanjing University, Nanjing, Jiangsu, China.
- College of Food Science and Light Industry, Nanjing Tech University, Nanjing, China.
ORCID profiles: Qi Zhang
Funding
- Jiangsu Provincial Key Research and Development Program
Cite
APA
Zhou, Y. F., Hou, Y. Y., Ban, Q., Zhang, M. L., Huang, T., Ma, B., Shi, L., & Zhang, Q. (2023). Metabolomics profiling of seminal plasma in obesity‐induced asthenozoospermia. Andrology, 11(7), 1303-1319. https://doi.org/10.1111/andr.13412
Vancouver
Zhou YF, Hou YY, Ban Q, Zhang ML, Huang T, Ma B, et al. Metabolomics profiling of seminal plasma in obesity‐induced asthenozoospermia. Andrology. 2023;11(7):1303-1319. doi:10.1111/andr.13412
BibTeX
@article{Zhou2023,
author = {Zhou, Yan-Fen and Hou, Yu-Yang and Ban, Qian and Zhang, Meng-Ling and Huang, Tao and Ma, Bo and Shi, Liang and Zhang, Qi},
title = {Metabolomics profiling of seminal plasma in obesity‐induced asthenozoospermia},
journal = {Andrology},
year = {2023},
volume = {11},
number = {7},
pages = {1303--1319},
doi = {10.1111/andr.13412}
}
EUVIMED